An Unusual Presentation of Tuberculosis in a Crohn’s Disease Patient Treated With Anti-TNF
In view of the increase in the therapeutic arsenal available for the treatment of inflammatory bowel disease in recent years, concerns about safety and side effects of immunosuppressive therapies have been increasingly common in clinical practice. The combination of thiopurines and anti-tumor necros...
Main Authors: | Luísa Leite Barros, Alexandre de Sousa Carlos, Matheus Freitas Cardoso de Azevedo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Gastro Hep Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572322000796 |
Similar Items
-
Anti-TNF treatment and miliary tuberculosis in Crohn’s disease
by: Milenković Branislava, et al.
Published: (2011-01-01) -
Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
by: Chenglin Ye, et al.
Published: (2022-04-01) -
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
by: Elen Farinelli de Campos Silva, et al.
Published: (2018-10-01) -
Coexisting Crohn’s Disease and Takayasu’s Arteritis in Two Patients Treated with Anti-TNF-α Therapies
by: S. Ratuapli, et al.
Published: (2010-02-01) -
Miliary Tuberculosis in a Crohn’s Disease Patient: The Risk beyond the Screening
by: Liliana Pereira Carvalho, et al.
Published: (2018-03-01)